Epizyme, Inc.
PRMT5 inhibitors and uses therof
Last updated:
Abstract:
Described herein are compounds of Formula (I), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting PRMT5 activity. Methods of using the compounds for treating PRMT5-mediated disorders are also described. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
15 Dec 2017
Issue date:
27 Aug 2019